EP 1675594 A2 20060705 - NOVEL DIPEPTIDYL PEPTIDASE IV INHIBITORS USED FOR FUNCTIONALLY INFLUENCING DIFFERENT CELLS AND TREATING IMMUNOLOGICAL, INFLAMMATORY, NEURONAL, AND OTHER DISEASES
Title (en)
NOVEL DIPEPTIDYL PEPTIDASE IV INHIBITORS USED FOR FUNCTIONALLY INFLUENCING DIFFERENT CELLS AND TREATING IMMUNOLOGICAL, INFLAMMATORY, NEURONAL, AND OTHER DISEASES
Title (de)
NEUE DIPEPTIDYLPEPTIDASE IV-INHIBITOREN ZUR FUNKTIONELLEN BEEINFLUSSUNG UNTERSCHIEDLICHER ZELLEN UND ZUR BEHANDLUNG IMMUNOLOGISCHER, ENTZÜNDLICHER, NEURONALER UND ANDERER ERKRANKUNGEN
Title (fr)
NOUVEAUX INHIBITEURS DE DIPEPTIDYLPEPTIDASES IV DESTINES A INFLUENCER LE FONCTIONNEMENT DE DIVERSES CELLULES ET A TRAITER DES MALADIES IMMUNOLOGIQUES, INFLAMMATOIRES, NEURONALES ET AUTRES
Publication
Application
Priority
- EP 2004011645 W 20041015
- DE 10348022 A 20031015
Abstract (en)
[origin: WO2005037779A2] The invention relates to medicinally used substances which specifically inhibit peptidases splitting Gly-Pro-p-nitroanilide. The invention further relates to the use of at least one such substance or at least one pharmaceutical or cosmetic composition containing at least one such substance for preventing and treating diseases, particularly diseases with an overshooting immune response (autoimmune diseases, allergies, and transplant rejections), other chronic inflammatory diseases, neuronal diseases, brain damages, skin diseases (acne and psoriasis, among others), tumor diseases, and special viral infections (including SARS).
IPC 1-7
IPC 8 full level
A61K 31/55 (2006.01); C07C 229/34 (2006.01); C07C 235/56 (2006.01); C07C 243/28 (2006.01); C07C 251/80 (2006.01); C07C 251/86 (2006.01); C07C 255/61 (2006.01); C07C 259/14 (2006.01); C07C 271/28 (2006.01); C07C 311/08 (2006.01); C07C 311/19 (2006.01); C07C 311/29 (2006.01); C07C 323/60 (2006.01); C07C 327/48 (2006.01); C07D 205/08 (2006.01); C07D 213/82 (2006.01); C07D 225/02 (2006.01); C07D 401/12 (2006.01); C07D 405/12 (2006.01); C07D 417/12 (2006.01); C07F 9/6506 (2006.01)
CPC (source: EP US)
A61P 1/04 (2017.12 - EP); A61P 11/06 (2017.12 - EP); A61P 25/00 (2017.12 - EP); A61P 29/00 (2017.12 - EP); A61P 37/02 (2017.12 - EP); A61P 43/00 (2017.12 - EP); C04B 35/632 (2013.01 - EP US); C07C 229/34 (2013.01 - EP US); C07C 235/56 (2013.01 - EP US); C07C 243/28 (2013.01 - EP US); C07C 251/80 (2013.01 - EP US); C07C 251/86 (2013.01 - EP US); C07C 255/61 (2013.01 - EP US); C07C 259/14 (2013.01 - EP US); C07C 271/28 (2013.01 - EP US); C07C 311/08 (2013.01 - EP US); C07C 311/19 (2013.01 - EP US); C07C 311/29 (2013.01 - EP US); C07C 323/60 (2013.01 - EP US); C07C 327/48 (2013.01 - EP US); C07D 205/08 (2013.01 - EP US); C07D 213/82 (2013.01 - EP US); C07D 225/02 (2013.01 - EP US); C07D 401/12 (2013.01 - EP US); C07D 405/12 (2013.01 - EP US); C07D 417/12 (2013.01 - EP US); C07F 9/6506 (2013.01 - EP US); C07C 2601/10 (2017.04 - EP US); C07C 2603/74 (2017.04 - EP US)
Citation (search report)
See references of WO 2005037779A2
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PL PT RO SE SI SK TR
DOCDB simple family (publication)
WO 2005037779 A2 20050428; WO 2005037779 A3 20050707; AU 2004281959 A1 20050428; AU 2004281959 B2 20090723; AU 2004281959 B9 20091126; CA 2542807 A1 20050428; CN 1889960 A 20070103; DE 10348022 A1 20050525; EP 1675594 A2 20060705; JP 2008500270 A 20080110; US 2007037785 A1 20070215
DOCDB simple family (application)
EP 2004011645 W 20041015; AU 2004281959 A 20041015; CA 2542807 A 20041015; CN 200480034815 A 20041015; DE 10348022 A 20031015; EP 04790487 A 20041015; JP 2006534708 A 20041015; US 57588304 A 20041015